TerminatedNCT00535158
Vitamin D 2 to Dialysis Patients
Studying REN-related autosomal dominant tubulointerstitial kidney disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Brigham and Women's Hospital
- Principal Investigator
- Ajay K Singh, M.D.Brigham and Womens Hospital
- Intervention
- Ergocalciferol (Vitamin D 2)(drug)
- Enrollment
- 18 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2008 – 2009
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00535158 on ClinicalTrials.govOther trials for REN-related autosomal dominant tubulointerstitial kidney disease
Additional recruiting or active studies for the same condition.
See all trials for REN-related autosomal dominant tubulointerstitial kidney disease →